This grant supports genomics research across the pipeline, with relevance to lung cancer and mesothelioma in several streams. It prioritises improved access to genomic testing and liquid biopsy (Stream 1; $2.5 million; 5 years), discovery of new targets and disease models (Stream 2; $5million; 5 years), and integration of genomics into routine care (Stream 5; $3million; 5 years). Infrastructure funding (Stream 6; $6 million; 5 years) enables national data sharing and AI-driven analysis.
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198
Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.
Copyright © 2026 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.
